PROPEL INTERSECT ENT MINI 16MM MOMETASONE FUROATE IMPLANT [EACH]
The PROPEL® Mini sinus implant releases a steroid (mometasone furoate) over time. The implant starts to break down and be absorbed once placed into the sinus. A delivery system is used to insert the implant.
Propel Mini is comprised of approximately 69 mg of polymers composed of lactide, glycolide, caprolactone, ethylene glycol and 370 mcg of Mometasone Furoate.
The PROPEL® Mini Sinus Implant is intended for use as a medical device in patients after sinus surgery. It is used keep the ethmoid or frontal sinus open. It does this by spreading mucosal tissues, keeping the middle turbinate in place, stopping adhesions and reducing swelling. The PROPEL® Mini Sinus Implant reduces the need for some treatments after surgery, such as surgical adhesion lysis and/or use of oral steroids. Each PROPEL® Mini Sinus Implant contains 370µg of mometasone furoate. This is released over time to reduce swelling.
Sinus Indication: Ethmoid Sinus and Frontal Sinus Opening